486 related articles for article (PubMed ID: 16179381)
21. Identification of the oxidative 3alpha-hydroxysteroid dehydrogenase activity of rat Leydig cells as type II retinol dehydrogenase.
Hardy DO; Ge RS; Catterall JF; Hou YT; Penning TM; Hardy MP
Endocrinology; 2000 May; 141(5):1608-17. PubMed ID: 10803568
[TBL] [Abstract][Full Text] [Related]
22. Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer.
Ishizaki F; Nishiyama T; Kawasaki T; Miyashiro Y; Hara N; Takizawa I; Naito M; Takahashi K
Sci Rep; 2013; 3():1528. PubMed ID: 23524847
[TBL] [Abstract][Full Text] [Related]
23. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.
Mohler JL; Titus MA; Bai S; Kennerley BJ; Lih FB; Tomer KB; Wilson EM
Cancer Res; 2011 Feb; 71(4):1486-96. PubMed ID: 21303972
[TBL] [Abstract][Full Text] [Related]
24. Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.
Ando T; Nishiyama T; Takizawa I; Ishizaki F; Miyashiro Y; Takeda K; Hara N; Tomita Y
Sci Rep; 2016 Aug; 6():32198. PubMed ID: 27561382
[TBL] [Abstract][Full Text] [Related]
25. Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.
Penning TM; Bauman DR; Jin Y; Rizner TL
Mol Cell Endocrinol; 2007 Feb; 265-266():77-82. PubMed ID: 17223255
[TBL] [Abstract][Full Text] [Related]
26. Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens.
Jin Y; Penning TM
Biochemistry; 2006 Oct; 45(43):13054-63. PubMed ID: 17059222
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of dihydrotestosterone in human liver: importance of 3alpha- and 3beta-hydroxysteroid dehydrogenase.
Pirog EC; Collins DC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3217-21. PubMed ID: 10487690
[TBL] [Abstract][Full Text] [Related]
29. Assessment of steroidogenesis and steroidogenic enzyme functions.
Luu-The V
J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
[TBL] [Abstract][Full Text] [Related]
30. Androgen biosynthetic pathways in the human prostate.
Luu-The V; Bélanger A; Labrie F
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):207-21. PubMed ID: 18471780
[TBL] [Abstract][Full Text] [Related]
31. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism.
Jin Y; Penning TM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):79-94. PubMed ID: 11469812
[TBL] [Abstract][Full Text] [Related]
32. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
33. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
Ji Q; Chang L; VanDenBerg D; Stanczyk FZ; Stolz A
Prostate; 2003 Mar; 54(4):275-89. PubMed ID: 12539226
[TBL] [Abstract][Full Text] [Related]
34. Local androgen inactivation in abdominal visceral adipose tissue.
Blouin K; Richard C; Bélanger C; Dupont P; Daris M; Laberge P; Luu-The V; Tchernof A
J Clin Endocrinol Metab; 2003 Dec; 88(12):5944-50. PubMed ID: 14671194
[TBL] [Abstract][Full Text] [Related]
35. Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth.
Zhang B; Hu XJ; Wang XQ; Thériault JF; Zhu DW; Shang P; Labrie F; Lin SX
Biochem J; 2016 Apr; 473(8):1037-46. PubMed ID: 26929402
[TBL] [Abstract][Full Text] [Related]
36. 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats.
Frye CA; Edinger KL; Seliga AM; Wawrzycki JM
Psychoneuroendocrinology; 2004 Sep; 29(8):1019-27. PubMed ID: 15219653
[TBL] [Abstract][Full Text] [Related]
37. Binding and metabolism of 5alpha-androstane-3alpha, 17 beta-diol and of 5alpha-androstane-3beta, 17 beta-diol in the prostate, seminal vesicles and plasma of male rats: studies in vivo and in vitro.
Krieg M; Horst HJ; Sterba ML
J Endocrinol; 1975 Mar; 64(3):529-38. PubMed ID: 1133541
[TBL] [Abstract][Full Text] [Related]
38. Interconversion between 17 beta-hydroxy-5alpha-androstan-3-one (5alpha-dihydrotestosterone) and 5alpha-androstane-3alpha, 17 beta-diol in rat kidney: heterogeneity of 3alpha-hydroxysteroid oxidoreductases.
Verhoeven G; Heyns W; De Moor P
Eur J Biochem; 1976 Jun; 65(2):565-76. PubMed ID: 7455
[TBL] [Abstract][Full Text] [Related]
39. 5alpha-androstane-3alpha,17beta-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling.
Dozmorov MG; Yang Q; Matwalli A; Hurst RE; Culkin DJ; Kropp BP; Lin HK
Genomic Med; 2007; 1(3-4):139-46. PubMed ID: 18923939
[TBL] [Abstract][Full Text] [Related]
40. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]